m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
Syncom Formulations (India) Ltd logo

Syncom Formulations (India) Ltd Share Price

Current price unavailable.
As on - | -
PharmaceuticalsSmall Cap

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 13.6513.52
R213.9313.68
R314.3113.93
PP13.27 13.27
S113.6513.52
S212.6112.86
S3 12.3312.61

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-22.04-18.97-
ROE-16.7-14.38-
EPS0.230.180.210.160.14

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

April 7, 2026
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom Formulations India Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1988PLC047759</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VAISHALI AGRAWAL <br/> Designation: COMAPNY SECRETARY <br/> EmailId: finance@sfil.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: RAHUL VIJAY BANKDA <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: finance@sfil.in</div> </div> <div> <br/> Date: 07/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

About Syncom Formulations (India) Ltd

Equity img
Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom ...
ISIN :INE312C01025

Registered Office

7 Niraj Indl Estate Andheri(E),Off Mahakali Caves Rd

Contact number

+ 91-22-30887744

Registrars

Ankit Consultancy Pvt Ltd
Plot No. 60 Electronic Complex Pardeshipura Indore - 452010

Contact number

+ 91-0731-3198601/3198

Management

ANKIT KEDARMAL BANKDA (Chairman)

FAQs

The share price of Syncom Formulations (India) Ltd on the BSE is - as on -